BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 10657980)

  • 1. The importance of being proline: the interaction of proline-rich motifs in signaling proteins with their cognate domains.
    Kay BK; Williamson MP; Sudol M
    FASEB J; 2000 Feb; 14(2):231-41. PubMed ID: 10657980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of the proline-rich segment of myelin basic protein to SH3 domains: spectroscopic, microarray, and modeling studies of ligand conformation and effects of posttranslational modifications.
    Polverini E; Rangaraj G; Libich DS; Boggs JM; Harauz G
    Biochemistry; 2008 Jan; 47(1):267-82. PubMed ID: 18067320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural characterization of a new binding motif and a novel binding mode in group 2 WW domains.
    Ramirez-Espain X; Ruiz L; Martin-Malpartida P; Oschkinat H; Macias MJ
    J Mol Biol; 2007 Nov; 373(5):1255-68. PubMed ID: 17915251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of CH/π hydrogen bonds in recognition of the core motif in proline-recognition domains: an ab initio fragment molecular orbital study.
    Ozawa T; Okazaki K; Kitaura K
    J Comput Chem; 2011 Oct; 32(13):2774-82. PubMed ID: 21710635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure analysis and solution studies of human Lck-SH3; zinc-induced homodimerization competes with the binding of proline-rich motifs.
    Romir J; Lilie H; Egerer-Sieber C; Bauer F; Sticht H; Muller YA
    J Mol Biol; 2007 Feb; 365(5):1417-28. PubMed ID: 17118402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanism of NPF recognition by EH domains.
    de Beer T; Hoofnagle AN; Enmon JL; Bowers RC; Yamabhai M; Kay BK; Overduin M
    Nat Struct Biol; 2000 Nov; 7(11):1018-22. PubMed ID: 11062555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Energetics of Src homology domain interactions in receptor tyrosine kinase-mediated signaling.
    Ladbury JE; Arold ST
    Methods Enzymol; 2011; 488():147-83. PubMed ID: 21195228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proline-rich sequence recognition domains (PRD): ligands, function and inhibition.
    Freund C; Schmalz HG; Sticht J; Kühne R
    Handb Exp Pharmacol; 2008; (186):407-29. PubMed ID: 18491062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profilin binds proline-rich ligands in two distinct amide backbone orientations.
    Mahoney NM; Rozwarski DA; Fedorov E; Fedorov AA; Almo SC
    Nat Struct Biol; 1999 Jul; 6(7):666-71. PubMed ID: 10404225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition of proline-rich motifs by protein-protein-interaction domains.
    Ball LJ; Kühne R; Schneider-Mergener J; Oschkinat H
    Angew Chem Int Ed Engl; 2005 May; 44(19):2852-69. PubMed ID: 15880548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of EVH1, a novel proline-rich ligand-binding module involved in cytoskeletal dynamics and neural function.
    Fedorov AA; Fedorov E; Gertler F; Almo SC
    Nat Struct Biol; 1999 Jul; 6(7):661-5. PubMed ID: 10404224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and specificity studies of small-molecule ligands for SH3 protein domains.
    Inglis SR; Stojkoski C; Branson KM; Cawthray JF; Fritz D; Wiadrowski E; Pyke SM; Booker GW
    J Med Chem; 2004 Oct; 47(22):5405-17. PubMed ID: 15481978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From Src Homology domains to other signaling modules: proposal of the 'protein recognition code'.
    Sudol M
    Oncogene; 1998 Sep; 17(11 Reviews):1469-74. PubMed ID: 9779993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrin beta cytoplasmic domain interactions with phosphotyrosine-binding domains: a structural prototype for diversity in integrin signaling.
    Calderwood DA; Fujioka Y; de Pereda JM; García-Alvarez B; Nakamoto T; Margolis B; McGlade CJ; Liddington RC; Ginsberg MH
    Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2272-7. PubMed ID: 12606711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The protein interaction network mediated by human SH3 domains.
    Carducci M; Perfetto L; Briganti L; Paoluzi S; Costa S; Zerweck J; Schutkowski M; Castagnoli L; Cesareni G
    Biotechnol Adv; 2012; 30(1):4-15. PubMed ID: 21740962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A miniprotein scaffold used to assemble the polyproline II binding epitope recognized by SH3 domains.
    Cobos ES; Pisabarro MT; Vega MC; Lacroix E; Serrano L; Ruiz-Sanz J; Martinez JC
    J Mol Biol; 2004 Sep; 342(1):355-65. PubMed ID: 15313630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of PDZ domain specificity, prediction of ligand affinity and rational design of super-binding peptides.
    Wiedemann U; Boisguerin P; Leben R; Leitner D; Krause G; Moelling K; Volkmer-Engert R; Oschkinat H
    J Mol Biol; 2004 Oct; 343(3):703-18. PubMed ID: 15465056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural insight into the binding diversity between the human Nck2 SH3 domains and proline-rich proteins.
    Liu J; Li M; Ran X; Fan JS; Song J
    Biochemistry; 2006 Jun; 45(23):7171-84. PubMed ID: 16752908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examining the specificity of Src homology 3 domain--ligand interactions with alkaline phosphatase fusion proteins.
    Yamabhai M; Kay BK
    Anal Biochem; 1997 Apr; 247(1):143-51. PubMed ID: 9126384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain.
    Brasher BB; Roumiantsev S; Van Etten RA
    Oncogene; 2001 Nov; 20(53):7744-52. PubMed ID: 11753652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.